P. Pukhtinskaia

The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study

V. Mazurov, O. Moiseeva, M. Gilyarov, 2021, Inflammation research : official journal of the European Histamine Research Society ... [et al.].

Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR

V. Mazurov, A. Lila, M. Korolev, 2023, Rheumatology Science and Practice.